Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
T-cell-based immunotherapies provide a promising means of cancer treatment although durable antitumor responses are infrequent. A potential reason for these shortcomings may lie in the observed lack of trafficking of specific T cells to tumor. Our increasing knowledge of the process of trafficking involving adhesion molecules and chemokines affords us the opportunity to intervene and correct deficiencies in this process. Chemokines can be expressed by a range of tumors and may serve as suitable targets for directing specific T cells toward tumor. We initially sought to identify which chemokines were produced by a range of human tumor cell lines, and which chemokines and chemokine receptors were expressed by cultured T cells. We identified two chemokines: Growth-Regulated Oncogene-alpha (Gro-alpha; CXCL1) and Regulated on Activation Normal T Cell-Expressed and Secreted (RANTES; CCL5), to be secreted by several human tumor cell lines. Expression was also detected in fine-needle aspirates of melanoma from patients. In addition, we determined the expression of several chemokine receptors on cultured human T cells including CCR1, CCR2, CCR4, CCR5, CXCR3, and CXCR4. Cultured, activated human T cells expressed the chemokines lymphotactin (XCL1), RANTES, macrophage inflammatory protein-1 alpha (MIP-1 alpha; CCL3) and MIP-1 beta (CCL4), but no appreciable Gro-alpha. In a strategy to direct T cells toward chemokines expressed by tumors we chose Gro-alpha as the target chemokine because it was produced by tumor and not by T cells themselves. However, T cells did not express the receptor for Gro-alpha, CXCR2, and therefore, T cells were transduced with a retroviral vector encoding CXCR2. Calcium ion mobilization, an important first step in chemokine receptor signaling, was subsequently demonstrated in transduced T cells in response to Gro-alpha. In addition, Gro-alpha was chemotactic for T cells expressing CXCR2 in vitro toward both recombinant protein and tumor-derived chemokine. Interestingly we demonstrate, for the first time, that Gro-alpha was able to induce interferon-gamma (IFN-gamma) secretion from transduced T cells, thereby extending our knowledge of other potential functions of CXCR2. This study demonstrates the feasibility of redirecting the migration properties of T cells toward chemokines secreted by tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,226
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
Germain, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90336-0 · Cited by 1,434
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895 · Cited by 1,370
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,041
LIGAND RECOGNITION BY αβ T CELL RECEPTORS
Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B., & Chien, Y.-H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.523 · Cited by 924
Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 Receptor
Murphy, P. M., & Tiffany, H. L. (1991) · Science · doi:10.1126/science.1891716 · Cited by 871
Self-citationMig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 779
High-fidelity mRNA amplification for gene profiling
Wang, E., Miller, L. D., Ohnmacht, G. A., Liu, E. T., & Marincola, F. M. (2000) · Nature Biotechnology · doi:10.1038/74546 · Cited by 675
Self-citationConstruction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
Miller, A. D., Garcia, J. V., von Suhr, N., Lynch, C. M., Wilson, C., & Eiden, M. V. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2220-2224.1991 · Cited by 627
Chemokines in tissue-specific and microenvironment-specific lymphocyte homing
Campbell, J. J., & Butcher, E. C. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00096-0 · Cited by 625
Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants.
Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., Kuratsu, J., & Leonard, E. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1449 · Cited by 490
Activation of Dual T Cell Signaling Pathways by the Chemokine RANTES
Bacon, K. B., Premack, B. A., Gardner, P., & Schall, T. J. (1995) · Science · doi:10.1126/science.7569902 · Cited by 447
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
Schadendorf, D., Möller, A., Algermissen, B., Worm, M., Sticherling, M., & Czarnetzki, B. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2667 · Cited by 412
Clay, T. M., Custer, M. C., Sachs, J., Hwu, P., Rosenberg, S. A., & Nishimura, M. I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.507 · Cited by 410
Self-citationNegus, R. P. M., Stamp, G., Hadley, J., & Balkwill, F. R. (1997) · Europe PMC (PubMed Central) · Cited by 383
Van Damme, J., Proost, P., Lenaerts, J. P., & Opdenakker, G. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.59 · Cited by 371
Campbell, J. J., Bowman, E. P., Murphy, K., Youngman, K. R., Siani, M. A., Thompson, D. A., Wu, L., Zlotnik, A., & Butcher, E. C. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1053 · Cited by 317
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.
Bénard, J., Silva, J. D., Blois, M. C. D., Boyer, P. J. J., Duvillard, P., Chiric, E., & RIOU, G. F. (1985) · PubMed · Cited by 287
Chemokines and Chemokine Receptors: Biology and Clinical Relevance in Inflammation and AIDS
Locati, M., & Murphy, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.425 · Cited by 283
Hwu, P., Shafer, G. E., Treisman, J., Schindler, D. G., Gross, G., Cowherd, R., Rosenberg, S. A., & Eshhar, Z. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.361 · Cited by 256
Self-citationZachariae, C. O., Anderson, A. O., Thompson, H. L., Appella, E., Mantovani, A., Oppenheim, J. J., & Matsushima, K. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.6.2177 · Cited by 239
Integrating Conflicting Chemotactic Signals
Foxman, E. F., Kunkel, E. J., & Butcher, E. C. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.577 · Cited by 217
Chuntharapai, A., Lee, J., Hébert, C. A., & Kim, K. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5682 · Cited by 211
Luan, J., Shattuck-Brandt, R., Haghnegahdar, H., Owen, J. D., Strieter, R., Burdick, M., Nirodi, C., Beauchamp, D., Johnson, K. N., & Richmond, A. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.588 · Cited by 205
Pockaj, B. A., Sherry, R. M., Wei, J. P., Yannelli, J. R., Carter, C. S., Leitman, S. F., Carasquillo, J. A., Steinberg, S. M., Rosenberg, S. A., & Yang, J. C. (1994) · Cancer · doi:10.1002/1097-0142(19940315)73:6<1731::aid-cncr2820730630>3.0.co;2-h · Cited by 199
Rutledge, B. J., Rayburn, H., Rosenberg, R., North, R. J., Gladue, R. P., Corless, C. L., & Rollins, B. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4838 · Cited by 189
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
Haghnegahdar, H., Du, J., Wang, D., Strieter, R. M., Burdick, M. D., Nanney, L. B., Cardwell, N., Luan, J., Shattuck-Brandt, R., & Richmond, A. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.53 · Cited by 180
Oliveira, I. C., Sciavolino, P. J., Lee, T. H., & Vilcek, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9049 · Cited by 179
Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction
Ho, W., Blattman, J. N., Dossett, M. L., Yee, C., & Greenberg, P. D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00113-2 · Cited by 172
Loukinova, E., Dong, G., Enamorado-Ayalya, I., Thomas, G. R., Chen, Z., Schreiber, H., & Van Waes, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203687 · Cited by 172
Richmond, A., & Thomas, H. G. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360209 · Cited by 171
Expression of scatter factor and c‐ met receptor in benign and malignant breast tissue
Jin, L., Fuchs, A., Schnitt, S. J., Yao, Y., Joseph, A., Lamszus, K., Park, M., Goldberg, I. D., & Rosen, E. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<749::aid-cncr12>3.0.co;2-# · Cited by 164
Vaday, G. G., Franitza, S., Schor, H., Hecht, I., Brill, A., Cahalon, L., Hershkoviz, R., & Lider, O. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.885 · Cited by 138
Mrowietz, U., Schwenk, U., Maune, S., Bartels, J., Küpper, M., Fichtner, I., Schröder, J.-M., & Schadendorf, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690164 · Cited by 137
Rubin, J. T., Elwood, L. J., Rosenberg, S. A., & Lotze, M. T. (1989) · PubMed · Cited by 135
Yoong, K. F., Afford, S. C., Jones, R., Aujla, P., Qin, S., Price, K., Hubscher, S. G., & Adams, D. H. (1999) · Hepatology · doi:10.1002/hep.510300147 · Cited by 127
Kozak, S. L., & Kabat, D. (1990) · Journal of Virology · doi:10.1128/jvi.64.7.3500-3508.1990 · Cited by 80
Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen
Treisman, J. S., Hwu, P., Minamoto, S., Shafer, G., Cowherd, R., Morgan, R., & Rosenberg, S. (1995) · Blood · doi:10.1182/blood.v85.1.139.bloodjournal851139 · Cited by 71
Self-citationOgawa, M., Tsutsui, T., Zou, J.-P., Mu, J., Wijesuriya, R., Yu, W., Herrmann, S. H., Kubo, T., Fujiwara, H., & Hamaoka, T. (1997) · PubMed · Cited by 60
Chemokine Receptor Desensitization in Tumor-Bearing Mice
Kurt, R. A., Baher, A., Wisner, K. P., Tackitt, S., & Urba, W. J. (2001) · Cellular Immunology · doi:10.1006/cimm.2000.1754 · Cited by 55
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
Peng, L., Shu, S., & Krauss, J. C. (1997) · PubMed · Cited by 53
Expression of hepatocyte growth factor in human hepatocellular carcinoma
Guirouilh‐Barbat, J., Bail, B. L., Boussarie, L., Balabaud, C. P., Bioulac‐Sage, P., Desmoulière, A., Schuppan, D., & Rosenbaum, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00014-3 · Cited by 40
Kershaw, M. H., Westwood, J. A., Zhu, Z., Witte, L., Libutti, S. K., & Hwu, P. (2000) · Human Gene Therapy · doi:10.1089/10430340050207939 · Cited by 40
Self-citationCole, D. J., Taubenberger, J. K., Pockaj, B. A., Yannelli, J. R., Carter, C. S., Carrasquillo, J. A., Leitman, S. F., Steinberg, S. M., Rosenberg, S. A., & Yang, Y. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01525507 · Cited by 32
Cheung, N. V., Guo, H.-F., Modak, S. I., & Cheung, I. Y. (2003) · Hybridoma and Hybridomics · doi:10.1089/153685903322328938 · Cited by 26
Cited by
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2281 · Cited by 1,121
“Such an approach has been tested preclinically with GRO-a (29), and the active clinical efforts ongoing with adoptive T-cell transfer in cancer patients make this approach attractive to consider in the future.”
MethodKlebanoff, C. A., Gattinoni, L., Torabi-Parizi, P., Kerstann, K., Cardones, A. R., Finkelstein, S. E., Palmer, D. C., Antony, P. A., Hwang, S. T., Rosenberg, S. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503726102 · Cited by 969
Adoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Maalej, K. M., Merhi, M., Inchakalody, V. P., Mestiri, S., Alam, M., Maccalli, C., Cherif, H., Uddin, S., Steinhoff, M., Marincola, F. M., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01723-z · Cited by 618
Self-citationAdoptive T cell therapy for cancer in the clinic
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32446 · Cited by 553
Metadata
- Authors
- Kershaw, M. H., Wang, G., Westwood, J. A., Pachynski, R. K., Tiffany, H. L., Marincola, F. M., Wang, E., Young, H. A., Murphy, P. M., & Hwu, P.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2002-11
- Volume
- 13
- Issue
- 16
- Pages
- 1971-1980
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2076823120
- Cited by
- 297
- References
- 48
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.